| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Chelsea Sierra Voss | Director | $1,246,760 | 16 Jan 2026 | ||
| Paul Rivard | Chief Legal Officer | $444,000 | 24 Aug 2023 | ||
| Joshua N. Silverman | Executive Chairman, Director | $435,126 | 14 Nov 2025 | ||
| Bruce Bernstein | Director | $108,750 | 14 Nov 2025 | ||
| Stephen Friscia | Director | $108,750 | 14 Nov 2025 | ||
| Billy Joe White | Director | $84,581 | 14 Nov 2025 | ||
| Gary Rauch | Vice President of Finance | $54,375 | 14 Nov 2025 | ||
| Mitchell Glass | Director, Chief Medical Off., Director | $42,250 | 14 Nov 2025 | ||
| CRAIG EAGLE | Director | 07 Jun 2023 | |||
| Adam Kaplin | Chief Scientific Officer | 07 Jun 2023 | |||
| Christopher C. Chapman JR | President, Chief Med. Officer, Director | 07 Jun 2023 | |||
| Jude Uzonwanne | Director | 07 Jun 2023 | |||
| Christopher Schreiber | Director | 07 Jun 2023 | |||
| PharmaCyte Biotech, Inc. | 10%+ Owner | 04 Sep 2025 | |||
| Ian Rhodes | Interim CFO | 17 Apr 2025 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|